Investigators have reported the clinical relevance of high TS mRNA as a predictor of the resistance to 5-FU/cisplatin or S-1 in gastric cancer (Lenz et al, 1996; Ichikawa et al, 2004). Here, TYMS is linked to gastric cancer.